Lviv clinical bulletin 2023, 2(42): 72-78

https://doi.org/10.25040/lkv2023.02.072

Advances in the Investigation of Vascular Remodeling and Endothelial Function in Heart Disease Over the Past Decades (Literature Review and Own Results)

Posted onAuthorAdminЗалишити коментар / Leave a comment

V. Denesyuk

National Pirogov Memorial Medical University, Vinnytsya

Introduction. Studies of vascular remodeling and endothelial dysfunction induced by different cardiological pathologies are far from complete.

The aim of the study. To analyze recent advances in the investigation of vascular remodeling and endothelial dysfunction on the background of cardiological diseases according to literature database and own research results.

Materials and methods. Literature survey of 49 articles was supplemented with own research results.

Results. By means of dopplerography it was detected brachial artery hypertrophy, which is a risk factor for myocardial infarction and stroke. Endothelium, which secretes vasoactive substances (nitric oxide – NO, endothelin-1, prostacyclin, thromboxane, etc.) plays an important role in the histophysiology of coronary arteries. Dysfunction of endothelium plays a key role in the development of atherosclerosis, coronary heart disease, hypertension, heart failure even before the appearance of clinical signs of diseases. In myocardial infarction, the development of endothelial dysfunction was detected by various methods. The predictors of an unfavorable prognosis in patients with acute myocardial infarction with elevated ST-segment include a violation of endothelium-dependent vasodilatation as revealed by test for hyperemia. Similarly, an unfavorable prognostic factor in myocardial infarction is the increased level of endothelin-1.

Conclusions. In patients with arterial hypertension, coronary heart disease, unstable angina pectoris, myocardial infarction, hypertrophic remodeling of the brachial artery alongside with a decrease in endothelium-dependent vasodilatation were detected by various older and new methodes. Currently it is generally accepted that changes in arteries and disruption of endothelial function are the root cause of diseases of the heart and blood vessels. On the basis of the conducted research, correction of the detected changes is carried out, aimed at preventing the progression of diseases of the cardiovascular system.

References

  1. Barska OV. Cardiovascular events and late remodeling of the heart and blood vessels after acute coronary syndrome and increasing the effectiveness of preventive treatment. Vinnytsia: Edelweiss and K; 2022. 216 (Ukrainian).
  2. Burns SA, Schmidt EA, Kipshina ES et al. Predictors of adverse coronary events in patients with ST-segment elevation acute coronary syndrome undergoing percutaneous coronary interventions. Cardiology. 2010;7:15-20. (Russian).
  3. Bilous ZO, Abragamovich OO. Peculiarities of endothelial function, blood lipid spectrum and variable heart rate in patients with stable angina pectoris depend on the frequency of heart rates. Lviv Clinical 2016;4(16):8-13. (Ukrainian).
  4. Horobets NM. The role of biologically active compounds of nitric oxide in the development of arterial hypertension and its complications. Ukrainian Therapeutic Journal. 2016;2(49):81-84. (Ukrainian).
  5. Degtyar NI, Gerasimenko ND, Rasyn MS. Endothelium and systemic inflammation: the role of nuclear transcription factors and therapeutic possibilities. News of Medicine and Pharmacy. 2017;4(609):22-23. (Russian).
  6. Denesyuk VI. Diagnosis and treatment of the initial stage of heart failure in patients with coronary artery disease. Kyiv: Health; 1991. 150 p. (Russian).
  7. Denesyuk VI. Ischemic heart disease combined with hypertension. Vinnitsa; 1995. 392 p. (Russian).
  8. Denesyuk VI, Denesyuk OV. Internal medicine. Kovalenko VM, editor. Kyiv: Morion; 2019. 960 p. (Ukrainian).
  9. Denesyuk VI, Barska OV, Music NO. The role of endothelial nitric oxide synthase in atrial fibrillation. Materials of the VIII Scientific and Practical Conference of the Association of Arrhythmologists of Ukraine. Arithmology. 2018;2(26):42-43. (Ukrainian).
  10. Denesyuk OV. Effectiveness of brachial artery remodeling and endothelial dysfunction correction in concentric and eccentric left ventricular hypertrophy in patients with unstable angina and comorbid arterial hypertension. Likars’ka sprava. 2015;5:72-76. (Ukrainian).
  11. Denesyuk OV. Endothelial dysfunction and functional and structural changes in blood vessels in patients with unstable angina pectoris with comorbid arterial hypertension. Lviv Clinical Bulletin. 2015;1(1):17-20. (Ukrainian).
  12. Denesyuk OV. The effectiveness of optimal therapy in achieving the target blood pressure level, grade regression, brachial artery remodeling, and endothelial dysfunction in patients after an acute ST-segment elevation myocardial infarction over two years. Bulletin of Problems Biology and Medicine. 2015;2(4):101-106. (Ukrainian).
  13. Denesyuk OV, Denesyuk VI. Development of endothelial dysfunction, vascular remodeling and dyslipidemia in patients with unstable angina pectoris with comorbid arterial hypertension. Blood Circulation and Hemostasis. 2012;4:57-63. (Ukrainian).
  14. Dotsenko NYa, Boev SS, Shehunova IA, Gerasimenko LV. Vascular biomarkers: method of research, indicators, clinical, prognostic value and perspectives. Heart and Vessels. 2018;2(62):89-99. (Russian).
  15. Yena LM, Yarosh VO. Endothelial dysfunction and its relationship with the morphofunctional state of the heart and arteries in patients with hypertension complicated by heart failure with preserved left ventricular ejection fraction. Heart and Vessels. 2016;3(55):71-76. (Ukrainian).
  16. Ivanyuk NB, Zharinov ОJ, Mikhalev КO, Еpanchintseva ОА, Тоdurov BМ. Changes of left ventricular ejection fraction in patients with ischemic cardiomyopathy after coronary artery bypass grafting. Ukrainian Journal of Cardiology. 2016;4:45-54. (Ukrainian).
  17. Knyazkova II, Tsygankov AI, Dalash-zade SR. Effect of kartopril on changes in endothelial factors in patients with acute myocardial infarction. Ukrainian Journal of Cardiology. 2004;80-84. (Russian).
  18. Kovalevska LA. Diastolic heart failure? Ukrainian Therapeutic Journal. 2011;2(30):97-102. (Ukrainian).
  19. Kravchun PG, Lapshina LA, Glebova OV. Endothelial function and cardiohemodynamics in clusters separated by the level of endothelin-1 in acute myocardial infarction and the late postinfarction period. International Medical Journal. 2012;1(18):22-26. (Ukrainian).
  20. Malyarska NV, Kalinichenko MA. Endothelial dysfunction as a universal predictor of the development of cardiovascular pathology and the possibility of its correction in the practice of a family doctor. Medicines of Ukraine. 2017;1(207):38-41. (Ukrainian).
  21. Mayanskaya SD, Grebenkina IA. Structural and functional remodeling of the vessel wall in persons with a history of arterial hypertension. Cardiology. 2015;2:27-31. (Russian).
  22. Mishchenko LA, Kupchynska OG, Matova OO, Serbeniuk KI, Gulkevych OV. Resistant arterial hypertension: clinical and pathogenetic features and predictors of therapy effectiveness. Ukrainian Journal of Cardiology. 2019;4(26):77-89. (Ukrainian).
  23. Oleinikov VE, Matrosova IB, Sergatskaya NV et al. Diagnostic value and clinical significance of the arterial stiffness assessment method – cardio-iliac vascular index. Terapevticheskii Arkhiv. 2010;9:68-72. (Russian).
  24. Omelyanenko MG, Sukhovei NA, Nazarov SB, Plekhanov VG. Clinical significance of endothelial dysfunction in non-ST-segment-elevation acute coronary syndrome in subjects under 55 years of age. Russian Journal of Cardiology. 2003;4(42):36-40. (Russian).
  25. Parkhomenko OM, Amosova KM, Kovalenko VM et al. Recommendations of cardiologists of Ukraine regarding the management of patients with acute coronary syndrome with ST segment elevation. Ukrainian Journal of Cardiology. 2013;(2 Suppl):3-51. (Ukrainian).
  26. Parkhomenko ОМ, Irkin OІ, Lutai YaM, Kushnir SP, Bіlyi DО, Stepura AО. Comparative evaluation of efficacy and safety of the different modes of lipid-lowering therapy in acute myocardial infarction. Ukrainian Therapeutic Journal. 2016;5:17-23. (Russian).
  27. Parkhomenko AN, Lutai YaM, Irkin OI et al. Clinical-prognostic value of endothelial NO synthase gene polymorphism in patients with acute coronary syndrome. Medicine of Emergency Conditions. 2014;3(58):45-53. (Ukrainian).
  28. Roitman AP, Tankhilevich BM, Dolgov VV et al. Dynamics of laboratory markers of endothelial dysfunction in the treatment of patients with unstable angina. Clinical Medicine. 2012;9:43-46. (Ukrainian).
  29. Sychov OS, Borodai AA, Fedkiv SV et al. Predictors of new brain necrosis revealed by multislice computer tomography. Arithmology. 2015;4(16):38-46. (Russian).
  30. Amer MS, Elawam AE, Khater MS, Omar OH, Mabrouk RA, Taha HM. Assosiation of high-sensitivity C-reactive protein with carotid intima-thickness in hypertensive older adults. J Am Soc Hypertens. 2011;5(5):395-400.
  31. Balkestein EJ, Staessen JA, Wang JG, van Der Heijden-Spek JJ, Van Bortel LM, Barlassina C et al. Carotid and femoral artery stiffness in relation to three candidate genes in a white population. Hypertension. 2001;38(5):1190-1197.
  32. Ciccone MM, Scicchitano P, Zito A, Agati L, Gesualdo M, Mandolesi S et al. Correlation between coronary artery disease seventy, left ventricular mass index and carotid intima media thickness, assessed by radio frequency. Cardiovac Ultrasound. 2011;9:32.
  33. Cleland JGF, Torabi A, Khan NK. Epidemiology and management of heart failure and left ventricular systolic dysfunction in the aftermath of a myocardial infarction. Heart. 2005;91(2 Suppl):107-113.
  34. Coutinho T, Borlaug BA, Pellikka PA, Turner ST, Kullo IJ. Sex differences in arterial stiffnessand ventricular-arterial interactions. J Am Coll Cardiol. 2013;61(1):96-103.
  35. Davies MJ. The pathophysiology of acute coronary syndromes. Heart. 2000;83(3):361-366.
  36. Denesiuk V, Muzyka N. The influence of the abclominal usage of Arginine on the factors of vasodilatation and the clinical data, complicated with cardial decompensation with reduced and preserved fracture of the ventricle that patients with stable coronary heart diseace have. Asian Journal of Science and Technology. 2017;08(04):4689-4697.
  37. Denesyuk VI, Denesyuk OV, Muzyka NO. The remodeling of left atrium and vasodilatation factors changes in inchemic heart failure. International Journal of Medicine and Medical Reserarch. 2016;2(2):5-91.
  38. Esper RJ, Nordaby RA, Vilariño JO, Paragano A, Cacharrón JL, Machado RA. Endotelial dysfunction: a comprehensive appraisal. Cardiovasc Diabetol. 2006;5:
  39. Flamer AJ, Luscher TF. Human endothelial dysfunction: EDREs. Pflugers Arch. 2010;459(6):1005-1013.
  40. Fox KM. Efficacy of perindopril in reduction cardiovascular events among patients with stable coronary artery disease: randomized, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet. 2003;362(9386):782-788.
  41. Hafner F, Seinost G, Gary T, Froehlich H, Pilger E, Brodmann M. Are flow-mediated vasodilatation and intima-media thickness of the brachial artery associated with restenosis after endovascular treatment of peripheral arterial occlusive disease? Eur Radiol. 2010;20(10):2533-2540.
  42. Harrison DG. Cellular and molecular mechanisms of endothelial cell dysfunction. J Clin Invest. 1997;100(9):2153-2157.
  43. Khare A, Shetty S, Ghosh K, Mohanty D, Chatterjee S. Evaluation of markers of endothelial damage in case of young myocardial infarction. Atherosclerosis. 2005;180(2):375-380.
  44. Lieberman EH, Gerhard MD, Uehata A, Selwyn AP, Ganz P, Yeung AC et al. Flow-induced vasodilatation the human brachial artery is impaired in patients < 40 year of age with coronary artery disease. Am J Cardiol. 1996;78(2):1210-1214.
  45. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness. A systematic review and meta-analysis. 2007;115(4):459-467.
  46. Lusher TF, Barton M. Biology of the endothelium. Clin С 1997;20(11 Suppl 2):3-10.
  47. Lusher TF, Barton M. Endothelins and endothellin receptor antagonists; therapeutic considerations for a novel class of cardiovascular drugs. Circulation. 2000;102(19):2434-2440.
  48. Preda I, Bencze J, Vargova K. Endothelial function and ischaemic heart disease. Orv Hetil. 2005;146(20 Suppl 2):1047-1053.
  49. Vane JR, Anggard EE, Botting RM. Regulatory functions of the vascular endothelium. N Eng J Med. 1990;323(1):27-36.